- Technical challenges of working with extracellular vesicles
MI Ramirez, MG Amorim, C Gadelha, I Milic, JA Welsh, VM Freitas, ...
Nanoscale 10 (3), 881-906 2018
Citations: 539
- Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features
JC de Oliveira, CA Scrideli, MS Brassesco, AG Morales, JA Pezuk, ...
Leukemia Research 36 (3), 293-298 2012
Citations: 113
- Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma
JA Pezuk, MS Brassesco, AG Morales, JC De Oliveira, ...
Cancer gene therapy 20 (9), 499-506 2013
Citations: 70
- MicroRNAs: understanding their role in gene expression and cancer
AL Jorge, ER Pereira, CS Oliveira, ES Ferreira, ETN Menon, SN Diniz, ...
Einstein (Sao Paulo) 19, eRB5996 2021
Citations: 45
- Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation
JA Pezuk, MS Brassesco, AG Morales, JC de Oliveira, HF de Oliveira, ...
Cancer Biotherapy and Radiopharmaceuticals 28 (7), 516-522 2013
Citations: 45
- Inhibition of NF‐κB by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ‐Radiation Cytotoxicity in
MS Brassesco, GM Roberto, AG Morales, JC Oliveira, LEA Delsin, ...
Chemotherapy research and practice 2013 (1), 593020 2013
Citations: 45
- BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells
AG Morales, JA Pezuk, MS Brassesco, JC de Oliveira, ...
Child's Nervous System 29, 2241-2248 2013
Citations: 44
- In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells.
JC de Oliveira, MS Brassesco, JA Pezuk, AG Morales, ET Valera, ...
Journal of drugs in dermatology: JDD 11 (5), 587-592 2012
Citations: 42
- In vitro targeting of Polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors
MS Brassesco, JA Pezuk, AG Morales, J Carvalho de Oliveira, ...
Cancer biology & therapy 14 (7), 648-657 2013
Citations: 39
- Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma
L Sales, JA Pezuk, KS Borges, MS Brassesco, CA Scrideli, LG Tone, ...
BMC Complementary and Alternative Medicine 15, 1-8 2015
Citations: 38
- Expression profiles and prognostic value of miRNAs in retinoblastoma
LEA Delsin, KB Salomao, JA Pezuk, MS Brassesco
Journal of Cancer Research and Clinical Oncology 145, 1-10 2019
Citations: 36
- MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells
JC Oliveira, MS Brassesco, AG Morales, JA Pezuk, PF Fedatto, ...
Asian Pac J Cancer Prev 12 (11), 3001-3004 2011
Citations: 35
- Pyroptosis in combinatorial treatment to improve cancer patients' outcome, is that what we want?
JA Pezuk
EBioMedicine 41, 17-18 2019
Citations: 34
- Should we keep rocking? Portraits from targeting Rho kinases in cancer
GR de Sousa, GM Vieira, PF das Chagas, JA Pezuk, MS Brassesco
Pharmacological research 160, 105093 2020
Citations: 31
- BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity
AG Morales, MS Brassesco, JA Pezuk, JC Oliveira, AP Montaldi, ...
Anti-cancer drugs 22 (10), 995-1001 2011
Citations: 31
- Sndrome de Burn-out: um olhar para o esgotamento profissional do docente universitrio
EC Ferreira, JA Pezuk
Avaliao: Revista da Avaliao da Educao Superior (Campinas) 26, 483-502 2021
Citations: 30
- MiRNA dysregulation in childhood hematological cancer
J Carvalho de Oliveira, G Molinari Roberto, M Baroni, K Bezerra Salomo, ...
International journal of molecular sciences 19 (9), 2688 2018
Citations: 30
- G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
AM Castro-Gamero, JA Pezuk, MS Brassesco, LG Tone
Cancer biology & medicine 15 (4), 354-374 2018
Citations: 28
- E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer
CM Lopes-Ramos, BP Barros, FC Koyama, PA Carpinetti, J Pezuk, ...
PLoS One 12 (7), e0181153 2017
Citations: 27
- BI 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments
RFE Bogado, JA Pezuk, HF de Oliveira, LG Tone, MS Brassesco
Anti-cancer drugs 26 (1), 56-63 2015
Citations: 25